HIGH-VOLUME · FEMALE-LED

levonorgestrel Side Effects

levonorgestrel (also sold as Plan B, Mirena) is HIGH-VOLUME in this FAERS book #29 of 524 by FAERS report count. Signature opener: FEMALE-LED - 99% of sex-coded reports are female (194,108 F / 1,680 M).

Data updated 2026-05-15

197,074
FAERS reports

FAERS voluntary reports, 2004 to 2025. High volume tracks exposure and reporting culture; see methodology for de-dup rules.

levonorgestrel reporting skew - 99% of sex-coded reports are female (194,108 F / 1,680 M). Volume band HIGH-VOLUME #29 of 524 by FAERS report count; caseload MEGA-CASE.

High-report extract for levonorgestrel (Plan B): 197,074 FAERS rows (2004-2025). Top named reactions: DEVICE EXPULSION, DEVICE DISLOCATION, MENSTRUATION IRREGULAR. Outcome stamps DEATH-RARE · HOSP-LIGHT · FEMALE-LED. FAERS is voluntary signal detection, not incidence.

Counts from the openFDA FAERS extract (2004–2025). Stamps MEGA-CASE · DEATH-RARE · HOSP-LIGHT · FEMALE-LED.

DEVICE EXPULSION leads 44,866 of 197,074 reports

DEVICE EXPULSION
44,866
DEVICE DISLOCATION
19,863
MENSTRUATION IRREGULAR
14,989
VAGINAL HAEMORRHAGE
14,819
GENITAL HAEMORRHAGE
10,916
ABDOMINAL PAIN LOWER
9,175
ABDOMINAL PAIN
8,552
NAUSEA
8,441
PROCEDURAL PAIN
8,262
PAIN
7,480
UTERINE PERFORATION
7,396
PELVIC PAIN
6,801
HEADACHE
6,407
PREGNANCY WITH CONTRACEPTIVE DEVICE
5,890
MENSTRUATION DELAYED
5,744
INTRA-UTERINE CONTRACEPTIVE DEVICE EXPELLED
5,574
COMPLICATION OF DEVICE INSERTION
5,532
FATIGUE
5,184
DYSMENORRHOEA
5,009

FEMALE-LED reporters · age peak 18-44

Female-led reporters (99% of sex-coded rows)

Female 194,108 (99%)
Male 1,680 (1%)
Unknown 77

Age peak 18-44 (106,973 reports)

0-17 4,850 (4%)
18-44 106,973 (87%)
45-64 10,397 (8%)
65-74 85 (0%)
75+ 35 (0%)

FAERS filings rising toward 2025

2004 2025

Reactions in Death Reports

Death is rare in this extract (267 / 197,074). Co-reported reactions in that thin subset:

Reaction Reports
DEATH 52
FOETAL EXPOSURE DURING PREGNANCY 21
PREMATURE BABY 16
COMPLETED SUICIDE 15
PAIN 13
SEPSIS 13
ABDOMINAL PAIN 11
ANXIETY 11
DEPRESSION 11
DEHYDRATION 9
FOETAL DEATH 9
PREGNANCY WITH CONTRACEPTIVE DEVICE 9
PULMONARY EMBOLISM 9
PYREXIA 9
CARDIAC ARREST 8
DRUG EXPOSURE DURING PREGNANCY 8
DYSPNOEA 8
FATIGUE 8
HEADACHE 8
VOMITING 8

Reactions in Hospitalization Reports

Hospitalization is lighter here (10,709). Reactions in that subset:

Reaction Reports
UTERINE PERFORATION 3,146
INJURY 3,018
PAIN 2,310
EMOTIONAL DISTRESS 1,857
ANXIETY 1,800
DEVICE DISLOCATION 1,667
ABDOMINAL PAIN 1,651
DEVICE ISSUE 1,610
DEPRESSION 1,492
ABDOMINAL PAIN LOWER 1,130
PELVIC PAIN 1,031
GENITAL HAEMORRHAGE 983
PREGNANCY WITH CONTRACEPTIVE DEVICE 769
PROCEDURAL PAIN 739
GENERAL PHYSICAL HEALTH DETERIORATION 641
DEVICE DIFFICULT TO USE 614
EMBEDDED DEVICE 573
MEDICAL DEVICE DISCOMFORT 571
VAGINAL HAEMORRHAGE 564
How to read levonorgestrel FAERS figures (MEGA-CASE · DEATH-RARE · HOSP-LIGHT)

FAERS holds 197,074 voluntary reports linked to levonorgestrel (Plan B, Mirena), 2004-2025. Death is listed on 267 (0.1%). Hospitalization appears on 10,709 (5.4%). Top co-reported indication: Contraception.

MEGA-CASE books overweight common drugs and loud reporting cultures; FEMALE-LED is the page opener, not a per-patient risk.

Read with levonorgestrel

Peers ranked by ABS(total_reports), then an ABS(death_share) pole; guide hop follows DEATH-RARE · HOSP-LIGHT stamps.